Christopher A. Chapleau

1.1k total citations
22 papers, 824 citations indexed

About

Christopher A. Chapleau is a scholar working on Genetics, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher A. Chapleau has authored 22 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher A. Chapleau's work include Genetics and Neurodevelopmental Disorders (14 papers), Autism Spectrum Disorder Research (6 papers) and Nerve injury and regeneration (5 papers). Christopher A. Chapleau is often cited by papers focused on Genetics and Neurodevelopmental Disorders (14 papers), Autism Spectrum Disorder Research (6 papers) and Nerve injury and regeneration (5 papers). Christopher A. Chapleau collaborates with scholars based in United States, Japan and Argentina. Christopher A. Chapleau's co-authors include Lucas Pozzo‐Miller, Jennifer Larimore, Alan K. Percy, Gastón Diego Calfa, Anne B. Theibert, Shinichi Kudo, Asher J. Albertson, Dawna L. Armstrong, Michelle D. Amaral and Jane B. Lane and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Human Molecular Genetics.

In The Last Decade

Christopher A. Chapleau

21 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher A. Chapleau United States	15	443	331	323	265	173	22	824
Jessica A. Burket United States	21	364 0.8×	381 1.2×	418 1.3×	318 1.2×	53 0.3×	49	1000
Prescott T. Leach United States	14	345 0.8×	430 1.3×	356 1.1×	232 0.9×	54 0.3×	22	819
Margaret K. King United States	9	452 1.0×	375 1.1×	380 1.2×	150 0.6×	52 0.3×	11	783
Victorio Bambini-Júnior Brazil	17	343 0.8×	247 0.7×	535 1.7×	149 0.6×	66 0.4×	30	1.0k
Steven C. Bakker Netherlands	19	178 0.4×	290 0.9×	195 0.6×	179 0.7×	65 0.4×	27	1.0k
Tomoyasu Wakuda Japan	13	236 0.5×	281 0.8×	370 1.1×	140 0.5×	77 0.4×	21	921
H.K. Manji United States	10	151 0.3×	305 0.9×	138 0.4×	306 1.2×	44 0.3×	18	829
Marija M. Petrinovic United Kingdom	9	113 0.3×	136 0.4×	226 0.7×	228 0.9×	78 0.5×	16	532
Thuy N. Vien United States	12	416 0.9×	415 1.3×	67 0.2×	241 0.9×	43 0.2×	19	748
Élise Morice France	10	168 0.4×	258 0.8×	115 0.4×	264 1.0×	47 0.3×	13	575

Countries citing papers authored by Christopher A. Chapleau

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Chapleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Chapleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Chapleau more than expected).

Fields of papers citing papers by Christopher A. Chapleau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Chapleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Chapleau. The network helps show where Christopher A. Chapleau may publish in the future.

Co-authorship network of co-authors of Christopher A. Chapleau

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Chapleau. A scholar is included among the top collaborators of Christopher A. Chapleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Chapleau. Christopher A. Chapleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, Eric C., Christopher A. Chapleau, Holly Robinson, et al.. (2024). A small-molecule TrkB ligand improves dendritic spine phenotypes and atypical behaviors in female Rett syndrome mice. Disease Models & Mechanisms. 17(6). 1 indexed citations

Orandi, Babak J., Geling Li, Deepti Dhall, et al.. (2021). Acute Liver Failure in a Healthy Young Female With COVID‐19. JPGN Reports. 2(3). e108–e108. 9 indexed citations

Chapleau, Christopher A., et al.. (2017). Cdk5 Is Essential for Amphetamine to Increase Dendritic Spine Density in Hippocampal Pyramidal Neurons. Frontiers in Cellular Neuroscience. 11. 372–372. 12 indexed citations

Cross, Rebecca, Stephanie A. Zlatic, Christopher A. Chapleau, et al.. (2016). The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin. Frontiers in Cellular Neuroscience. 10. 218–218. 16 indexed citations

Chapleau, Christopher A., et al.. (2013). Is memantine a potential therapeutic for Rett syndrome?. Frontiers in Neuroscience. 7. 245–245. 6 indexed citations

Shord, Stacy S., Terry L. Schwinghammer, Melissa E. Badowski, et al.. (2013). Desired Professional Development Pathways for Clinical Pharmacists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(4). e34–42. 25 indexed citations

Pitcher, Meagan R., Christopher Ward, Elsa M. Arvide, et al.. (2013). Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function. Human Molecular Genetics. 22(13). 2626–2633. 34 indexed citations

Chapleau, Christopher A., Jane B. Lane, Lucas Pozzo‐Miller, & Alan K. Percy. (2013). Evaluation of Current Pharmacological Treatment Options in the Management of Rett Syndrome: From the Present to Future Therapeutic Alternatives.. Current Clinical Pharmacology. 8(4). 358–369. 22 indexed citations

Chapleau, Christopher A., Jane B. Lane, Susan M. Kirwin, et al.. (2013). Detection of rarely identified multiple mutations in MECP2 gene do not contribute to enhanced severity in rett syndrome. American Journal of Medical Genetics Part A. 161(7). 1638–1646. 4 indexed citations

10.

Arnold, John J., Mark Hansen, Gregory S. Gorman, et al.. (2013). The Effect of Rho-Associated Kinase Inhibition on the Ocular Penetration of Timolol Maleate. Investigative Ophthalmology & Visual Science. 54(2). 1118–1118. 24 indexed citations

11.

Larimore, Jennifer, Pearl V. Ryder, Kun‐Yong Kim, et al.. (2013). MeCP2 Regulates the Synaptic Expression of a Dysbindin-BLOC-1 Network Component in Mouse Brain and Human Induced Pluripotent Stem Cell-Derived Neurons. PLoS ONE. 8(6). e65069–e65069. 38 indexed citations

12.

Chapleau, Christopher A., Elena Boggio, Gastón Diego Calfa, et al.. (2012). Hippocampal CA1 Pyramidal Neurons ofMecp2Mutant Mice Show a Dendritic Spine Phenotype Only in the Presymptomatic Stage. Neural Plasticity. 2012. 1–9. 40 indexed citations

13.

Chapleau, Christopher A., Jane B. Lane, Jennifer Larimore, et al.. (2012). Recent Progress In Rett Syndrome and Mecp2 Dysfunction: Assessment of Potential Treatment Options. Future Neurology. 8(1). 21–28. 28 indexed citations

14.

Calfa, Gastón Diego, Christopher A. Chapleau, Susan L. Campbell, et al.. (2011). HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons. Hippocampus. 22(7). 1493–1500. 59 indexed citations

15.

Chapleau, Christopher A., David R. Luthin, & John M. Westfall. (2010). Antidepressant-Induced Sexual Dysfunction: Five Management Strategies. 50(7). 282–286. 1 indexed citations

16.

Larimore, Jennifer, Christopher A. Chapleau, Shinichi Kudo, et al.. (2009). Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiology of Disease. 34(2). 199–211. 99 indexed citations

17.

Chapleau, Christopher A., Jennifer Larimore, Anne B. Theibert, & Lucas Pozzo‐Miller. (2009). Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. Journal of Neurodevelopmental Disorders. 1(3). 185–196. 77 indexed citations

18.

Chapleau, Christopher A., Gastón Diego Calfa, Asher J. Albertson, et al.. (2009). Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiology of Disease. 35(2). 219–233. 187 indexed citations

19.

Chapleau, Christopher A., et al.. (2007). The actions of BDNF on dendritic spine density and morphology in organotypic slice cultures depend on the presence of serum in culture media. Journal of Neuroscience Methods. 169(1). 182–190. 57 indexed citations

20.

Amaral, Michelle D., Christopher A. Chapleau, & Lucas Pozzo‐Miller. (2006). Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: Potential implications for Rett syndrome. Pharmacology & Therapeutics. 113(2). 394–409. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact